Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: Results of a prospective randomized trial

Transplantation Proceedings

Volumn 42, Issue 10, 2010, Pages 4441-4448

  Herlenius, G ^a   Felldin, M ^a   Norden G ^a   Olausson, M ^b   Backman L ^a   Gustafsson, B ^a   Friman, S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; EDETATE CHROMIUM CR 51; LOW MOLECULAR WEIGHT HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; CANDIDIASIS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESOPHAGUS VARICES; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAM NEGATIVE SEPSIS; HEPATIC ARTERY THROMBOSIS; HERPES ZOSTER; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOBAR PNEUMONIA; MALE; MOUTH ULCER; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SEPSIS; SIDE EFFECT; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT DURATION; URINARY TRACT INFECTION; VAGINA MYCOSIS; VEIN THROMBOSIS;

ADULT; ANTIHYPERTENSIVE AGENTS; CALCINEURIN; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 78650437607     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.113     Document Type: Conference Paper

References (26)

1. ELTR http://www.ELTR.org Accessed November 1, 2009
2. A.O. Ojo, P.J. Held, and F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931
3. R.A. Lafayette, G. Pare, and C.H. Schmid Pretransplant renal dysfunction predicts poorer outcome in liver transplantation Clin Nephrol 48 1997 159
4. R.S. Brown Jr., M. Lombardero, and J.R. Lake Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation Transplantation 62 1996 1788
5. T.A. Gonwa, G.B. Klintmalm, and M. Levy Impact of pretransplant renal function on survival after liver transplantation Transplantation 59 1995 361
6. S. Nair, S. Verma, and P.J. Thuluvath Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation Hepatology 35 2002 1179
7. P.T. Pham, P.C. Pham, and A.H. Wilkinson Management of renal dysfunction in the liver transplant recipient Curr Opin Organ Transplant 14 2009 231
8. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, classification, and stratification Am J Kidney Dis 39 2002 s1
9. J. Brochner-Mortensen A simple method for the determination of glomerular filtration rate Scand J Clin Lab Invest 30 1972 271
10. T.A. Gonwa, L. Jennings, and M.L. Mai Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations Liver Transpl 10 2004 301
11. C.J. Watson, A.E. Gimson, and G.J. Alexander A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function Liver Transpl 13 2007 1694
12. P. De Simone, H.J. Metselaar, and L. Fischer Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial Liver Transpl 15 2009 1262
13. WMA World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects http://www.wma.net/e/policy/pdf/ 17c.pdf 2007 Accessed November 9, 2009
14. S.A. Farkas, A.A. Schnitzbauer, and G. Kirchner Calcineurin inhibitor minimization protocols in liver transplantation Transpl Int 22 2008 49
15. H.J. Schlitt, A. Barkmann, and K.H. Boker Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study Lancet 357 2001 587
16. G. Orlando, L. Baiocchi, and A. Cardillo Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension Liver Transpl 13 2007 46
17. J.I. Herrero, J. Quiroga, and B. Sangro Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil Liver Transpl Surg 5 1999 414
18. S. Shenoy, K.L. Hardinger, and J. Crippin Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial Transplantation 83 2007 1389
19. K.D. Fairbanks, J.A. Eustace, and D. Fine Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus Liver Transpl 9 2003 1079
20. D. DuBay, R.J. Smith, and K.G. Qui Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens Liver Transpl 14 2008 651
21. G. Herlenius, J. Fistouris, and M. Olausson Early renal function post-liver transplantation is predictive of progressive chronic kidney disease Scand J Gastroenterol 43 2008 344
22. E. Velidedeoglu, R.D. Bloom, and M.D. Crawford Early kidney dysfunction post liver transplantation predicts late chronic kidney disease Transplantation 77 2004 553
23. E.M. Yoshida, P.J. Marotta, and P.D. Greig Evaluation of renal function in liver transplant recipients receiving declizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial Liver Transpl 11 2005 1064
24. H.P. Marti, and F.J. Frey Nephrotoxicity of rapamycin: an emerging problem in clinical medicine Nephrol Dial Transplant 20 2005 13
25. G.S. Jensen, A. Wiseman, and J.F. Trotter Sirolimus conversion for renal preservation in liver transplantation: not so fast Liver Transpl 14 2008 601
26. P.A. Senior, B.W. Paty, and S.M. Cockfield Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing Am J Transplant 5 2005 2318